When it comes to advocating for rheumatology, it’s never too early or late in your career to begin, and no effort is too small to have an impact, says Dr. Ziglar, a private practitioner and member of the Government Affairs Committee.
State-level wins that ensure immunosuppressed patients can access COVID-19 vaccination show the power of coordinated efforts by volunteer leaders, staff and members to translate the ACR’s work into actionable public policy recommendations, then amplify those messages through member engagement.
The U.S. House of Representatives passed the American Rescue Plan Act of 2021 (H.R. 1319) on March 10, 2021, after Senate passage on March 6. President Biden signed the bill into law on March 11. Following is the ACR’s summary of the most impactful provisions of this third COVID-19 relief package. Fighting COVID-19 $160 billion…
The ACR has joined with a coalition of organizations dedicated to improving the health and wellbeing of children and adolescents to request $50 million to fund the Pediatric Subspecialty Loan Repayment Program.
Introduced in the Senate on Feb. 25, the bill would amend the Employee Retirement Income Security Act to provide a clear process and circumstances for requesting medical exceptions to step therapy protocols.
Now in its 16th year, the Wisconsin Rheumatology Association engages and supports rheumatology professionals through advocacy sessions, annual meetings and continuing medical education-accredited events.
To say it has been an interesting (the science and the memes), tumultuous (the politics) and heartbreaking (the pandemic and social injustice) year is an understatement. There have been moments of grace and inspiration that we hope have kept everyone going. As we look to 2021, we take lessons from our experiences in 2020. Washington,…
New state legislatures face many continuing issues, including budget shortfalls, vaccine distribution problems and strained healthcare infrastructure. However, opportunities exist for significant policy wins for rheumatology, particularly on the issues of step therapy reform, telemedicine and copay accumulators.
At the virtual interim meeting Nov. 13–17, the ACR delegation led a successful bid to update American Medical Association policies on home infusion and copay accumulators and supported efforts against the Most Favored Nation drug pricing model.